China’s stocks fall on Monday as a cooling pace of initial public offerings failed to offset large losses in financial and healthcare stocks.
The blue-chip CSI300 index fell 0.5 percent, to while the Shanghai Composite Index lost 0.4 percent.
The China Securities Regulatory Commission approved on Friday only four IPOs to raise up to $220.48 million, down from 7 IPOs in the past week.
Expectations of the IPOs continuing at the pace seen in the past months had pressured the market, in particular those small-caps with relatively higher valuations.
China’s stocks fall on Monday as a cooling pace of initial public offerings failed to offset large losses in financial and healthcare stocks.
The blue-chip CSI300 index fell 0.5 percent, to while the Shanghai Composite Index lost 0.4 percent.
The China Securities Regulatory Commission approved on Friday only four IPOs to raise up to $220.48 million, down from 7 IPOs in the past week.
Expectations of the IPOs continuing at the pace seen in the past months had pressured the market, in particular those small-caps with relatively higher valuations.
China’s stocks fall on Monday as a cooling pace of initial public offerings failed to offset large losses in financial and healthcare stocks.
The blue-chip CSI300 index fell 0.5 percent, to while the Shanghai Composite Index lost 0.4 percent.
The China Securities Regulatory Commission approved on Friday only four IPOs to raise up to $220.48 million, down from 7 IPOs in the past week.
Expectations of the IPOs continuing at the pace seen in the past months had pressured the market, in particular those small-caps with relatively higher valuations.
China’s stocks fall on Monday as a cooling pace of initial public offerings failed to offset large losses in financial and healthcare stocks.
The blue-chip CSI300 index fell 0.5 percent, to while the Shanghai Composite Index lost 0.4 percent.
The China Securities Regulatory Commission approved on Friday only four IPOs to raise up to $220.48 million, down from 7 IPOs in the past week.
Expectations of the IPOs continuing at the pace seen in the past months had pressured the market, in particular those small-caps with relatively higher valuations.
China’s stocks fall on Monday as a cooling pace of initial public offerings failed to offset large losses in financial and healthcare stocks.
The blue-chip CSI300 index fell 0.5 percent, to while the Shanghai Composite Index lost 0.4 percent.
The China Securities Regulatory Commission approved on Friday only four IPOs to raise up to $220.48 million, down from 7 IPOs in the past week.
Expectations of the IPOs continuing at the pace seen in the past months had pressured the market, in particular those small-caps with relatively higher valuations.
China’s stocks fall on Monday as a cooling pace of initial public offerings failed to offset large losses in financial and healthcare stocks.
The blue-chip CSI300 index fell 0.5 percent, to while the Shanghai Composite Index lost 0.4 percent.
The China Securities Regulatory Commission approved on Friday only four IPOs to raise up to $220.48 million, down from 7 IPOs in the past week.
Expectations of the IPOs continuing at the pace seen in the past months had pressured the market, in particular those small-caps with relatively higher valuations.
China’s stocks fall on Monday as a cooling pace of initial public offerings failed to offset large losses in financial and healthcare stocks.
The blue-chip CSI300 index fell 0.5 percent, to while the Shanghai Composite Index lost 0.4 percent.
The China Securities Regulatory Commission approved on Friday only four IPOs to raise up to $220.48 million, down from 7 IPOs in the past week.
Expectations of the IPOs continuing at the pace seen in the past months had pressured the market, in particular those small-caps with relatively higher valuations.
China’s stocks fall on Monday as a cooling pace of initial public offerings failed to offset large losses in financial and healthcare stocks.
The blue-chip CSI300 index fell 0.5 percent, to while the Shanghai Composite Index lost 0.4 percent.
The China Securities Regulatory Commission approved on Friday only four IPOs to raise up to $220.48 million, down from 7 IPOs in the past week.
Expectations of the IPOs continuing at the pace seen in the past months had pressured the market, in particular those small-caps with relatively higher valuations.